Telix Pharmaceuticals Limited (ASX: TLX)
Australia flag Australia · Delayed Price · Currency is AUD
24.95
-0.07 (-0.28%)
Dec 27, 2024, 4:10 PM AEST

Telix Pharmaceuticals Revenue

Telix Pharmaceuticals had revenue of 188.96M AUD in the quarter ending June 30, 2024, with 58.05% growth. This brings the company's revenue in the last twelve months to 645.68M, up 80.92% year-over-year. In the year 2023, Telix Pharmaceuticals had annual revenue of 502.55M with 213.90% growth.

Revenue (ttm)
645.68M
Revenue Growth
+80.92%
P/S Ratio
12.53
Revenue / Employee
1.53M
Employees
234
Market Cap
8.35B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023502.55M342.45M213.90%
Dec 31, 2022160.10M152.50M2,007.64%
Dec 31, 20217.60M2.38M45.71%
Dec 31, 20205.21M1.73M49.58%
Dec 31, 20193.49M3.29M1,687.18%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition